bioMérieux S.A. (BMXMF)

R&D Expenses

€1.17B

TTM · Period ending: · EUR

BMXMF logo

BMXMF R&D Expenses

Latest reported€1.17B EUR
BMXMF TTM R&D Expenses · EUR (€397.60M → €1.17B)
High-resolution chart · PNG

BMXMF r&d expenses history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

bioMérieux S.A. R&D Expenses — Trailing twelve months (TTM) (EUR)
Period endingR&D Expenses (EUR)
1,173,113,074
1,176,698,387
1,139,100,000
951,600,000
960,000,000
906,700,000
880,600,000
835,600,000
791,500,000
784,700,000
771,700,000
768,200,000
784,500,000
740,200,000
701,600,000
672,100,000
607,000,000
576,300,000
543,400,000
510,800,000
470,400,000
444,700,000
422,800,000
397,600,000
434,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.